Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Tanya L. Wallace, Daniel Bertrand
Expert Opinion on Therapeutic Targets (2012) Vol. 17, Iss. 2, pp. 139-155
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 467
Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery
Jeremías Corradi, Cecilia Bouzat
Molecular Pharmacology (2016) Vol. 90, Iss. 3, pp. 288-299
Open Access | Times Cited: 151
Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity
Bernard Bloem, Rogier B. Poorthuis, Huibert D. Mansvelder
Frontiers in Neural Circuits (2014) Vol. 8
Open Access | Times Cited: 135
Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex
Tanya L. Wallace, Daniel Bertrand
Biochemical Pharmacology (2013) Vol. 85, Iss. 12, pp. 1713-1720
Closed Access | Times Cited: 130
Therapeutic Potential ofα7 Nicotinic Acetylcholine Receptors
Daniel Bertrand, Chih-Hung L. Lee, Dorothy G. Flood, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1025-1073
Open Access | Times Cited: 130
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Jared W. Young, Mark A. Geyer
Biochemical Pharmacology (2013) Vol. 86, Iss. 8, pp. 1122-1132
Open Access | Times Cited: 121
Cholinergic nervous system and glaucoma: From basic science to clinical applications
Muneeb A. Faiq, Gadi Wollstein, Joel S. Schuman, et al.
Progress in Retinal and Eye Research (2019) Vol. 72, pp. 100767-100767
Open Access | Times Cited: 106
Negative affective states and cognitive impairments in nicotine dependence
F. Scott Hall, Andre Der‐Avakian, Thomas J. Gould, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 58, pp. 168-185
Open Access | Times Cited: 91
Allosteric modulation of nicotinic acetylcholine receptors
Anna Chatzidaki, Neil S. Millar
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 408-417
Closed Access | Times Cited: 90
Stoichiometry for activation of neuronal α7 nicotinic receptors
Natalia Andersen, Jeremías Corradi, Steven M. Sine, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 51, pp. 20819-20824
Open Access | Times Cited: 83
Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy
Dean F. Wong, Hiroto Kuwabara, Martin G. Pomper, et al.
Molecular Imaging and Biology (2014) Vol. 16, Iss. 5, pp. 730-738
Open Access | Times Cited: 71
Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective
Natalia Andersen, Beatriz E Nielsen, Jeremías Corradi, et al.
Neuropharmacology (2016) Vol. 107, pp. 189-200
Open Access | Times Cited: 62
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Robert C. Smith, Revital Amiaz, Tian-Mei Si, et al.
PLoS ONE (2016) Vol. 11, Iss. 1, pp. e0143490-e0143490
Open Access | Times Cited: 61
Derivatives of Dibenzothiophene for Positron Emission Tomography Imaging of α7-Nicotinic Acetylcholine Receptors
Gao Y, Kenneth J. Kellar, Robert P. Yasuda, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 19, pp. 7574-7589
Open Access | Times Cited: 58
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 656-667
Open Access | Times Cited: 53
Molecular Modulation of Human α7 Nicotinic Receptor by Amyloid-β Peptides
Matías Lasala, Camila Fabiani, Jeremías Corradi, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 50
Lynx Prototoxins: Roles of Endogenous Mammalian Neurotoxin-Like Proteins in Modulating Nicotinic Acetylcholine Receptor Function to Influence Complex Biological Processes
Julie M. Miwa, K. Anderson, Katie M. Hoffman
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 48
A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders
Daniel Bertrand, Tanya L. Wallace
Current topics in behavioral neurosciences (2020), pp. 1-28
Closed Access | Times Cited: 40
Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders
Chien‐Hsing Lee, Shih‐Ya Hung
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 31-31
Open Access | Times Cited: 25
Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists
Yu Xue, Jingshu Tang, Xiaozhuo Ma, et al.
European Journal of Medicinal Chemistry (2016) Vol. 115, pp. 94-108
Closed Access | Times Cited: 41
Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers
Verner Knott, Sara de la Salle, Joëlle Choueiry, et al.
Pharmacology Biochemistry and Behavior (2015) Vol. 131, pp. 119-129
Closed Access | Times Cited: 38
Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats
Patrick M. Callahan, Alvin V. Terry, Ashok Tehim
Psychopharmacology (2014) Vol. 231, Iss. 18, pp. 3695-3706
Open Access | Times Cited: 37
Development of [ 18 F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography
Andrew G. Horti
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 566-575
Open Access | Times Cited: 33
Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders
Roger B. Clark, Diana Lamppu, Lyn Libertine, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 10, pp. 3966-3983
Closed Access | Times Cited: 30
Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays
Milan Stoiljković, Liza Leventhal, Angela Chen, et al.
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 576-589
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top